Faraz Ali

Chief Executive Officer at TENAYA THERAPEUTICS, INC.

Net worth: 371 370 $ as of 31/08/2026

53 year

70 connections

Health Technology

Consumer Services

Health Services

Profile

Faraz Ali is President, Chief Executive Officer & Director at Tenaya Therapeutics, Inc. since 2026 and has been with the company since 2018.
Mr. Ali is also Director at Alliance for Regenerative Medicine since 2023.
Former roles include Head-U.S.
Marketing & Strategic Planning at Genzyme Corp.
from 2001 to 2010, Chief Business Officer at REGENXBIO, Inc. from 2016 to 2018, and Vice President-Global Commercial Development at Genetix Biotherapeutics, Inc. from 2011 to 2016.
Education includes undergraduate studies at Stanford University and an MBA from Harvard Business School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
TENAYA THERAPEUTICS, INC. 0.24%	10/09/2026	539,782 ( 0.24% )	371 370 $	31/08/2026

Faraz Ali active positions

Companies	Position	Start
TENAYA THERAPEUTICS, INC.	Chief Executive Officer	01/06/2018
Alliance for Regenerative Medicine Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine	Director/Board Member	01/01/2023

All active positions of Faraz Ali

Former positions of Faraz Ali

Companies	Position	End
REGENXBIO INC.	Corporate Officer/Principal	05/01/2018
GENETIX BIOTHERAPEUTICS, INC.	Corporate Officer/Principal	01/02/2016
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Corporate Officer/Principal	01/11/2010

See the detail of Faraz Ali's experience

Training of Faraz Ali

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Faraz Ali's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
REGENXBIO, Inc. REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy	Health Technology
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
bluebird bio, Inc. bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells	Health Technology
Alliance for Regenerative Medicine Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine	Health Services
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tenaya Therapeutics, Inc. Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure	Health Technology